New York, New York, May 22, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC ("Univest"), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered offering (the "Offering") for its client WORK Medical Technology Group LTD (NASDAQ:WOK) (the "Company"), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China. Under the terms of the securities purchase agreement, the Company has agreed to sell to several investors for the purchase and sale of an aggregate of 10,000,000 ordinary units (the "Ordinary Uni

Hangzhou, China, May 22, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (NASDAQ:WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced the closing of a registered offering (the "Offering") of 10,000,000 ordinary units (the "Ordinary Units") at an offering price of $0.50 per Ordinary Unit. Each Ordinary Unit consists of one Class A ordinary share, par value $0.0005 (a "Class A Ordinary Share"), one Series A warrant to purchase one Class A Ordinary Share at an exercise price of $1.00 (a "Series A Warrant"), and one Series B warrant

Hangzhou, China, May 21, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (NASDAQ:WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced the pricing of a registered offering (the "Offering") of 10,000,000 ordinary units (the "Ordinary Units") or pre-funded units (the "Pre-funded Units") in lieu thereof at an offering price of $0.50 per Ordinary Unit and $0.4995 per Pre-funded Unit. For each Pre-funded Unit sold by the Company, the number of Ordinary Units being offered by the Company will be decreased on a one-for-one basis. Each O

Hangzhou, China, April 11, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (NASDAQ:WOK) ("WORK Medical" or the "Company"), a supplier of medical devices, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on April 7, 2025, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of US$1.00 pe

Hangzhou, China, March 05, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (NASDAQ:WOK) ("WORK Medical" or the "Company"), a supplier of medical devices, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced the implementation of its dual-class share structure, effective March 6, 2025. About WORK Medical Technology Group LTD WORK Medical Technology Group LTD is a supplier of medical devices that develops and manufactures Class I and II medical devices and sells Class I and II disposable medical devices through operating subsidiaries in China. The Company has a diverse product portfolio comprising 21 product

Hangzhou, China, Feb. 28, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (NASDAQ:WOK) ("WORK Medical" or the "Company"), a supplier of medical devices, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced a strategic partnership with Shanghai Chartwell Medical Device Co., Ltd. ("Chartwell Medical"), a high-end medical products manufacturer across diverse fields, including nuclear medicine, imaging, infection control, ophthalmology, and rehabilitation robotics, to drive industrial synergy and accelerate their growth in the healthcare sector. The collaboration is to be carried out through Chartwell Medical's

HANGZHOU, China, Feb. 14, 2025 /PRNewswire/ -- WORK Medical Technology Group LTD ("WORK Medical" or the "Company") (NASDAQ:WOK), a supplier of medical devices in China, today reported its financial results for the fiscal year ended September 30, 2024. Mr. Shuang Wu, Chairman and Chief Executive Officer of WORK Medical, remarked, "We are pleased to report our Company's performance for the fiscal year ended September 30, 2024. As the lingering effects of COVID-19 gradually subside and the global business environment returns to normal, our net revenue reflects a decline primarily due to a 69.4% decrease in mask sales. We have implemented a strategic transformation to drive growth in other key

Hangzhou, China, Nov. 27, 2024 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (NASDAQ:WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, today announced that its subsidiary, Hangzhou Shanyou Medical Equipment Co., Ltd. ("Hangzhou Shanyou"), participated in the MEDICA Trade Fair 2024 (the "Event"), held in Düsseldorf, Germany, from November 11 to November 14, 2024. The Event provided a platform through which Hangzhou Shanyou's products could garner interest and attention from international customers. This milestone underscores WORK Medical's strategic commitment to enhancing its global brand visibility and competing internationally in the low- and medium-

Hangzhou, China, Aug. 29, 2024 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (NASDAQ:WOK) (the "Company"), a supplier of medical devices in China, today announced the underwriter of its initial public offering (the "Offering") has partially exercised its over-allotment option to purchase an additional 91,942 ordinary shares at the public offering price of US$4.00 per share. After giving effect to the partial exercise of the over-allotment option, the total number of ordinary shares sold by the Company in the public offering increased to 2,091,942 ordinary shares and the gross proceeds increased to approximately $8.37 million, before deducting underwriting discounts and offering exp

Hangzhou, China, Aug. 26, 2024 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (NASDAQ:WOK) (the "Company"), a supplier of medical devices in China, today announced the closing of the initial public offering (the "Offering") of its 2,000,000 ordinary shares at a public offering price of US$4.00 per ordinary share. The ordinary shares commenced trading on the Nasdaq Capital Market on August 23, 2024 under the ticker symbol "WOK." The gross proceeds of the Offering were approximately US$8.00 million, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 300,000 ordinary

6-K - WORK Medical Technology Group LTD (0001929783) (Filer)

424B4 - WORK Medical Technology Group LTD (0001929783) (Filer)

EFFECT - WORK Medical Technology Group LTD (0001929783) (Filer)

F-1/A - WORK Medical Technology Group LTD (0001929783) (Filer)

6-K - WORK Medical Technology Group LTD (0001929783) (Filer)

F-1/A - WORK Medical Technology Group LTD (0001929783) (Filer)

6-K - WORK Medical Technology Group LTD (0001929783) (Filer)

20-F - WORK Medical Technology Group LTD (0001929783) (Filer)

6-K - WORK Medical Technology Group LTD (0001929783) (Filer)

NT 20-F - WORK Medical Technology Group LTD (0001929783) (Filer)